Efficacy of Deep Transcranial Magnetic Stimulation in Patients With Opioid Use Disorder

Launched by PAMUKKALE UNIVERSITY · Oct 8, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called Deep Transcranial Magnetic Stimulation (Deep TMS) to help people who have an opioid use disorder. The goal is to see if this treatment can reduce cravings and help prevent the use of opioids in patients who have already stopped using them for at least a week. The trial is currently looking for participants aged 18 to 65 who have been diagnosed with opioid use disorder.

To take part in the study, individuals must not be pregnant or breastfeeding, and they should not have certain mental health conditions or neurological diseases. During the trial, participants will receive the Deep TMS treatment, which involves using magnetic fields to stimulate specific areas of the brain. This non-invasive procedure is designed to be safe and may help in managing cravings for opioids. It's important to know that the study is open to everyone regardless of gender, and those interested in participating should check if they meet the eligibility requirements.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18- 65
• • Clinical diagnosis of opioid use disorder
• Exclusion Criteria:
• • Currently pregnant or breastfeeding
• • Mental retardation, bipolar disorder, any psychotic disorder
• • Neurological diseases such as epilepsy, ischemic stroke, multiple sclerosis
• • History of head trauma that resulted in loss of consciousness for ≥5 minutes and retrograde amnesia for ≥30 minutes (self-reported history)
• • Any history of seizures other than febrile childhood seizures (self-reported history)
• • Clinically significant hearing impairment
• • Having any prosthesis, such as an implant and pacemaker.
• • Illiteracy